EBS - What Is Going On With Emergent BioSolutions Shares? | Benzinga
Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals.
What Happened: On Thursday prior to the market open, Emergent BioSolutions announced it entered into a definitive agreement with Bora to sell the site for about $30 million.
Besides the acquisition of the site, about 350 Emergent employees ...